Profiling of tumor-draining LNs of mice showed that migratory cDC2s expressing CCR7 were responsible for initiating CD4+ T cell priming, but not differentiation, leading to defective anti-tumoral effector T cells. This evidence concerns the gene CD4 and neoplasm.